Filing Details
- Accession Number:
- 0001209191-21-065673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-18 21:12:25
- Reporting Period:
- 2021-11-17
- Accepted Time:
- 2021-11-18 21:12:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661460 | Poseida Therapeutics Inc. | PSTX | Biological Products, (No Disgnostic Substances) (2836) | 472846548 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816804 | D. Kerry Ingalls | C/O Poseida Therapeutics, Inc. 9390 Towne Centre Drive, Ste 200 San Diego CA 92121 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-17 | 2,000 | $7.00 | 2,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
